Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Anti-inflammatory effect of bergamot leaves extract attenuates cardiac remodeling in obese rats by regulating the protein expression of the collagen/metalloproteinase axis

Abstract

Inflammation is associated with the pathogenesis of obesity-related disorders, including cardiac remodeling. Bergamot is known for its promising anti-inflammatory effects. Thus, this study aimed to investigate the anti-inflammatory effect of bergamot leaves extract (BLE) in attenuating cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis. Male Wistar rats were fed a control diet (C) or a high sugar-fat diet (HSF) for 20 weeks. After developing cardiac remodeling, the animals were again distributed into three groups to receive BLE (50 mg/kg/day) or placebo (water) via gavage for 10 weeks: C, HSF and HSF + BLE. The HSF group exhibited obesity (HSF 8.77 ± 2.64 vs C 3.09 ± 1.02, p = 0.007), dyslipidemia (HSF 94.4 ± 19.1 vs C 26.7 ± 5.2, p < 0.001), hypertension (HSF 141 ± 8 vs C 120 ± 4, p = 0.001), insulin resistance (HSF 6.91 ± 1.38 vs C 2.47 ± 1.01, p < 0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 vs C 0.71 ± 0.07, p = 0.009) and increased type III collagen (HSF 1.32 ± 0.27 vs C 1.00 ± 0.18, p = 0.038). In contrast, BLE was effective in improving dyslipidemia (HSF + BLE 55.2 ± 9.7 vs HSF 94.4 ± 19.1, p < 0.001), insulin resistance (HSF + BLE 3.79 ± 0.76 vs HSF 6.91 ± 1.38, p < 0.001), cardiac remodeling and function, as well as inflammation, MMP-2 (HSF + BLE 0.84 ± 0.22 vs HSF 0.43 ± 0.09, p < 0.001) and type III collagen (HSF + BLE 0.68 ± 0.11 vs HSF 1.32 ± 0.27, p < 0.001) in the HSF group. Therefore, the anti-inflammatory effect of BLE improved cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis.

Introduction

Excess body fat causes cardiac abnormalities such as hemodynamic, morphological and functional changes, by different mechanisms, associated with the release of pro-inflammatory cytokines and collagen protein expression [14]. In situations of excessive nutrient intake, there is hypertrophy of the adipose tissue that initially triggers a local inflammatory response, characterized by increased synthesis of pro-inflammatory cytokines, such as tumor necrosis fator-alpha (TNF-α) and interleukin-6 (IL-6), which are strongly involved in the etiology of obesity-related cardiomyopathy. Recent studies from our research group demonstrate that this condition culminates in the cardiac production of inflammatory cytokines through the activation of the Toll-like pathway 4 (Toll-like receptor 4, TLR-4) [2,3,5].

Collagen is a component of the cardiac extracellular matrix (ECM), mainly types I and III, important for the maintenance of cardiac architecture and function. In contexts with alterations in the myocardial interstitial collagen, as a result of increased synthesis or a decreased degradation, there occurs an increase in tissue stiffness, culminating in cardiac remodeling, well established in pressure and volume overload models [4,6,7].

Alteration and/or impairment in cardiac performance occur with the increase in pro-inflammatory cytokines and interstitial collagen, the mechanisms related to the modulation of these responses are not well established in obesity models. One of the possibilities is the involvement of matrix metalloproteinases (MMPs), proteolytic enzymes responsible for degradation of collagen fibers. MMPs can be modulated by pro-inflammatory cytokines in different models [713] in particular MMP-2, the most abundant in the myocardium and related to the remodeling process [14].

Thus, considering the importance of inflammation in the pathogenesis of obesity-related disorders, including cardiac remodeling and dysfunction, the search for anti-inflammatory therapeutic strategies presents promising possibilities. Bergamot (Citrus bergamia), is a citrus fruit used for pharmaceutical purposes in the production of essential oil, which differs from the others not only by the composition of its profile of flavonoids present in the fruit juice, but also by the particularly high content of these compounds, which has aroused scientific interest because they perform hypolipemic, hypoglycemic, anti-inflammatory and antioxidant activities, proving to be effective in the treatment of the parameters that make up the metabolic syndrome [1517]. Recently, some investigations have shown a higher concentration of phenolic compounds in the leaves compared to the fruit, indicating a greater therapeutic potential [15,18].

Therefore, in view of the scarcity of studies that address the anti-inflammatory effect of bergamot leaves extract (BLE) in the treatment of heart diseases associated with obesity, the aim of the present study was to investigate the anti-inflammatory effect of BLE in attenuating cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis.

Materials and methods

Experimental protocol

All procedures involving animals were in compliance with the National Institute of Health’s Guide for the Care and Use of Laboratory Animals [19], and ethical approval was granted by the Ethics Committee of São Paulo State University (1393/2021) approved on 28 September 2021.

Groups characterization

The sample size of the present study was calculated based on the work on myocardial collagens I and III of obese rats fed a saturated high-fat diet [20]. Thus, a sample of 24 animals was estimated with a sampling power of 90%, a two-tailed alpha of 0.05, and a sample loss of approximately 25%. Male Wistar rats (±187 g, n = 24) were kept in an environmentally controlled room (22 °C ± 3 °C; 12 h light-dark cycle and relative humidity of 60 ± 5%) and randomly distributed into 2 experimental groups by 20 weeks. During this period, the animals received ad libitum water and a control diet (C, n = 8) or a high sugar-fat diet (HSF, n = 16) containing 25% sucrose. The diets were prepared in our laboratory as previously published [21]. After this period, echocardiography was performed on the animals, and a 95% confidence interval for cardiac remodeling was constructed based on morphological, systolic, and diastolic variables in the HSF and C groups. This criterion is important because animals subjected to different dietary models do not always exhibit the expected response. This can lead to misclassification of animals and, consequently, false conclusions [22]. Therefore, the HSF animals that did not develop cardiac remodeling were excluded from the experiment, and two animals in the control group died during the experiment due to gavage. After, the animals were redivided into 3 groups to begin treatment with BLE by gavage daily (50 mg/kg) for 10 weeks: control diet + placebo (C, n = 6), HSF diet + placebo (HSF, n = 6), HSF + BLE (n = 6). The nutritional composition of both diets is presented in Table 1.

At the end of 30 weeks, the animals were fasted for 8 h and then anesthetized with thiopental (120 mg/Kg/i.p.) and euthanized by decapitation after verification of the absence of palpebral, foot, interdigital and caudal reflexes. Blood samples were collected, and the plasma was separated by centrifugation (800 × g at 4 °C for 10 min) for metabolic analyses. The adipose tissue was isolated, dissected, and weighed for nutritional parameter assessment and cardiac tissue was also collected from each animal for further analysis.

BLE

Bergamot leaves were harvested in a farm located in the Reggio Calabria region, Italy, and the dry extract was obtained at H&AD (Herbal & Antioxidant Derivatives S.r.l.) plant located in Localit`a Chiusi, 89032 Bianco (RC), Italy (www.head-sa.com). The processes involved in the extraction and administration were described and published by our research group [23]. The dosage was defined according to published fruit juice data [24].

Nutritional and metabolic parameters

The nutritional parameters included the following parameters: chow fed, water intake, caloric intake, final body weight (FBW) and adiposity index. Caloric intake was determined by multiplying the energy value of each diet (g × Kcal) by the daily food consumption. For the HSF group, caloric intake also considered the calories from water (0.25 × 4 × mL consumed). After euthanasia, the fat deposits (visceral (VAT), epididymal (EAT) and retroperitoneal (RAT)) were used to calculate the adiposity index by the following formula [25]:

Triglycerides levels were measured using specific kits (BIOCLIN®, Belo Horizonte, MG, Brazil) and analyzed by a colorimetric-enzymatic method in an automatic enzymatic analyzer system (Chemistry Analyzer BS-200, Mindray Medical International Limited, Shenzhen, China). The homeostatic model of insulin resistance (HOMA-IR) was used as an insulin resistance index, calculated according to the formula [26]:

Glucose levels were measured in a blood drop using a handheld glucometer (Accu-Chek Performa, Roche Diagnostics Brazil Limited, São Paulo, Brazil), while insulin levels were assessed by an enzyme-linked immunosorbent assay (ELISA) method using commercial kits (Linco Research Inc., R&D Systems, Millipore and B-Brigde International Inc.) and the reading was performed in a Spectramax 190 microplate spectrophotometer (Molecular Devices®, Sunnyvale, CA, USA).

Systolic blood pressure (SBP)

Evaluation was assessed in conscious rats by the non-invasive tail-cuff method with a NarcoBioSystems® Electro-Sphygmomanometer (International Biomedical, Austin, TX, USA). The animals were kept in a wooden box (50 × 40 cm) between 38 and 40 °C for 4–5 min to stimulate arterial vasodilation [27]. After this procedure, a cuff with a pneumatic pulse sensor was attached to the tail of each animal. The cuff was inflated to 200 mmHg pressure and subsequently deflated. The blood pressure values were recorded on a Gould RS 3200 polygraph (Gould Instrumental, Valley View, OH, USA). The average of three pressure readings was recorded for each animal.

Echocardiographic study

Doppler echocardiographic evaluation was performed by a single examiner at the 20th and 30th weeks. Animals were anesthetized with ketamine (50 mg/kg, i.p.) and xylazine hydrochloride (1 mg/kg, i.p.). After trichotomy of the anterior chest region, the animals were placed in slight left lateral decubitus for the exam. The equipment used was model Vivid S6 (General Electric Medical Systems, Tirat Carmel, Israel) with a multifrequency ultrasonic transducer 5.0–11.5 MHz. To implement structural measurements of the heart, the images were obtained in one-dimensional mode (M-mode) guided by the images in two-dimensional mode with the transducer in the parasternal position, minor axis [23].

Left ventricular (LV) evaluation was performed by positioning the cursor M-mode just below the mitral valve plane at the level of the papillary muscles. The following cardiac structures were used to analyze cardiac morphology: left ventricular diastolic diameter (LVDD), posterior wall diastolic thickness (PWDT), interventricular septum diastolic thickness (IVSDT), left ventricular mass index (LVM index) and relative thickness of the left ventricular (LVRT). The systolic LV function was assessed by the following parameters: ejection fraction (EF) and posterior wall shortening velocity (PWSV). The LV diastolic function was evaluated using the following indices: isovolumic relaxation time (IVRT), E wave deceleration time (EWDT) and E/E′ ratio.

Cardiac inflammatory markers

Cardiac tissue samples were homogenized and centrifuged as already described by our research group [2,3]. The levels of TNF-α and IL-6 were evaluated using the ELISA method using commercial kits from R&D System, Minneapolis, USA. The results were corrected by the protein amount.

Myocardial MMP-2 activity

The activity was determined by the zymography technique as described by Tyagi et al. [28]. In brief, samples were diluted in extraction buffer with 50 mM of Tris pH 7.4, 0.2 M of sodium chloride (NaCl), 0.1% of Triton X, and 10 mM of calcium chloride (CaCl2). Protein in samples was quantified by the Bradford method [29]. Samples with 20 µg of protein were then diluted in application buffer with 0.5 M of Tris pH 6.8, 50% of glycerol, and 0.05% of bromophenol blue, and loaded into wells of 8% of sodium dodecyl sulfate (SDS) polyacrylamide containing 1% gelatin. Electrophoresis was run in a Bio-Rad apparatus at 80 V for 2 h. Gel was removed, washed with 2.5% of Triton X-100, and washed with 50 mM of Tris pH 8.4. Gel was then incubated at 37 °C overnight in activation solution with 50 mM of Tris pH 8.4, 5 mM of CaCl2, and zinc chloride (ZnCl2). Staining was performed for 2 h with 0.5% of comassie blue and destaining in 30% of methanol and 10% of acetic acid at room temperature on a rotatory shaker. To identify the gel activity of MMP-2, we used recombinant mouse/rat MMP-2 standard (R&D Systems) as a positive control. The gels were photographed by Gel Logic 6000 Pro (Carestream Health Inc.) and the intensity of gelatinolytic action (clear bands) was analyzed by GelPro 3.1 [30].

Myocardial type III collagen protein expression

LV samples were homogenized in RIPA buffer with protease and phosphatase cocktail inhibitors, and centrifuged for 20 min at 4 °C, for the supernatant collection. Protein concentration was determined by the Bradford method [29] and samples were diluted in Laemmli buffer and loaded (50 μg of protein) into a 10% SDS–polyacrylamide gel. Electrophoresis was performed in a Mini-Protean 3 Eletrophoresis Cell system (Bio-Rad, Hercules, USA), at 4 °C, at 50 V for 30 min and then at 120 V for 2 h. After that, the gels were transferred to a nitrocellulose membrane using Trans-Blot Turbo-Transfer System (BioRad) in a semi-wet transfer for 30 min at 25 V and 1.0 A, using transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol and 0.1% SDS). Next, the membranes were blocked in 5% bovine serum albumin solution at room temperature for 2 h in order to prevent unspecific bindings with antibodies and washed with basal solution (Tris 1 M, NaCl 2.5 M and Tween 20), pH 8.0. Incubation with primary antibodies was performed overnight at 4 °C in Tris-buffered saline solution containing Tween 20 (TBS-T) and 3% bovine serum albumin [5]. Antibody dilutions were 1:1000 for anti-collagen III (rabbit monoclonal antibody, ABCAM ab184993) and 1:1000 for anti-beta actin (rabbit polyclonal antibody, ABCAM ab8227). After incubating overnight at 4 °C in TBS-T containing 1% bovine serum albumin with the Abcam secondary antibodies (dilutions 1:5000 for goat anti-rabbit IgG H&L (HRP) (ABCAM ab205718)), proteins were revealed using the chemiluminescence method according to the manufacturer’s instructions (ECL SuperSignal® West Pico Chemiluminescent Substrate, Thermo Scientific). Band intensities were evaluated by ImageQuant TL 1D Version 8.1 (GE Healthcare Life Sciences). β-actin protein was used as an endogenous control.

Statistical analysis

Data are presented as means ± standard deviation or medians (interquartile range). Differences among the groups were determined by one-way ANOVA followed by post hoc Tukey’s test for parametric data or Kruskal-Wallis followed by post hoc Tukey’s test for non-parametric data. Statistical analyses were performed using Sigma Stat for Windows Version 3.5. (Systat Software, Inc., San Jose, CA, USA). A p value < 0.05 was considered as statistically significant.

Results

The nutritional and metabolic parameters are shown in Table 2. The HSF group showed increased water intake, caloric intake, final body weight, adiposity index, triglycerides and insulin resistance; however, chow intake was reduced when compared to the C group. The HSF + BLE group had improvement in insulin resistance, as indicated by HOMA-IR, and triglyceride levels compared to the HSF group.

Table 3 shows the cardiovascular parameters. The HSF group presented cardiac remodeling characterized by changes in structural variables (LVDD, PWDT, IVSDT, LVM index, LVRT), cardiac systolic and diastolic function (EF, PWSV, IVRT, EWDT and E/E’ ratio), and increased SBP. Treatment with BLE attenuated cardiac remodeling and recovered systolic and diastolic functions compared to the HSF group.

Fig 1 shows cardiac inflammatory parameters. TNF-α (Fig 1A) and IL-6 (Fig 1B) levels were higher in HSF than in the C group, representing an inflammatory state. The treatment with BLE attenuated the concentration of cardiac inflammatory parameters in the HSF + BLE group compared to the HSF group.

thumbnail
Fig 1. Cardiac inflammatory parameters.

(A) tumoral necrosis factor – alpha (TNF-α); (B) Interleukin- 6 (IL-6). Data are expressed in mean ± standard deviation or median (min-max) (6 animals/group). Comparison by one-way ANOVA or Kruskal-Wallis with Tukey’s post hoc. p < 0.05. C, Control diet+placebo; HSF, high sugar-fat diet+placebo; HSF + BLE, high sugar-fat diet+ bergamot leaves extract.

https://doi.org/10.1371/journal.pone.0334015.g001

Fig 2 (S1 Fig Raw image) shows MMP-2 activity. The HSF had lower MMP-2 activity than the C group. Supplementation with BLE increased the MMP-2 activity compared to the HSF group.

thumbnail
Fig 2. MMP-2 activity.

Data are expressed in mean ± standard deviation (6 animals/group). Comparison by one-way ANOVA with Tukey’s post-hoc. p < 0.05. C, Control diet+placebo; HSF, high sugar-fat diet+placebo; HSF + BLE, high sugar-fat diet+ bergamot leaves extract.

https://doi.org/10.1371/journal.pone.0334015.g002

Fig 3 (S2 Fig Raw image) shows the myocardial expression of collagen III/β-actin. It can be observed that the HSF group presented higher protein expression compared to the C group. On the other hand, BLE supplementation reduced collagen expression in the HSF + BLE group compared to the HSF and C groups.

thumbnail
Fig 3. Relative expression of collagen III/β-actin.

Data are expressed in mean ± standard deviation (6 animals/group). Comparison by one-way ANOVA with Tukey’s post-hoc. p < 0.05. C, Control diet+placebo; HSF, high sugar-fat diet+placebo; HSF + BLE, high sugar-fat diet+ bergamot leaves extract.

https://doi.org/10.1371/journal.pone.0334015.g003

Discussion

According to the literature, diets rich in fats and carbohydrates may be responsible for the pandemic of obesity and disorders related to excess body fat, such as insulin resistance, type 2 diabetes mellitus, high blood pressure and dyslipidemia [31,32]. The findings of the present study corroborate the literature, since the HSF group developed obesity, dyslipidemia, systolic arterial hypertension and insulin resistance (Tables 2 and 3), showing the effectiveness of the dietary model in providing obesity and its related disorders [21]. In contrast, HSF animals supplemented with BLE had improved insulin resistance and triglyceride levels. This improvement can be attributed to the high concentration of polyphenols present in bergamot, since both bergamot fruit and leaves extract share the same class of polyphenolic compounds, some of which are in higher concentrations in the leaves, and show promising results due to their antioxidant, anti-inflammatory, and hypolipidemic effects that culminate in improved glucose uptake and lipid metabolism [15,23,33].

Several studies, both in experimental models and humans, have sought to establish a dietary model capable of inducing cardiac remodeling and dysfunction [34]. This condition was confirmed in this study, since the HSF group showed cardiac remodeling (through an increase in LVDD, PWDT, IVSDT, LVM index and LVRT), accompanied by impairment of systolic and diastolic ventricular function (through a decrease in EF, PWSV and increase in IVRT, EWDT and E/E’ ratio) (Table 3). However, the mechanisms underlying cardiac remodeling are not yet fully understood, therefore, this study aimed to investigate the anti-inflammatory effect of BLE in attenuating cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis. The results showed that BLE supplementation attenuated cardiac remodeling and recovered systolic and diastolic function (Table 3). Remodeling induced by obesity can be explained by several mechanisms [5,7]. These include chronic and low-grade inflammatory states characterized by increased production of inflammatory cytokines, such as TNF-α and IL-6 [2,3,5,35]. Cytokines are involved in important cardiac processes such as myocyte hypertrophy, ventricular remodeling and left ventricular dysfunction [36]. Our findings confirm the evidence of the association between cardiac remodeling and inflammation, since the cardiac levels of TNF-α and IL-6 were higher in the HSF group (Fig 1A and 1B). The HSF + BLE group had recovery of cardiac alterations concomitant with a lower level of inflammatory cytokines, confirming the anti-inflammatory potential of BLE.

One of the hypotheses explaining the involvement of inflammatory cytokines in the cardiac remodeling process is their ability to modulate collagen deposition via the activity of matrix MMPs. MMPs play a key role in cardiac collagenolytic activity, especially the MMP-2, which degrades interstitial collagen types I and III, responsible for cardiac rigidity [6,37]. In our study, the HSF group had a reduction in MMP-2 activity (Fig 2) and an increase in the protein expression of collagen III (Fig 3). Supplementation with leaves extract increased MMP-2 activity and decreased collagen expression, confirming the ability of inflammatory cytokines to modulate MMP-2 activity and its subsequent regulation of interstitial collagen.

Different experimental models have been used to investigate the participation of the MMP-collagen pathway in cardiac remodeling [8,9,3840]. However, few studies have investigated the participation of this pathway in obesity models [8,41]. The studies that analyzed protein expression of collagen I and III in the heart of obese animals [8,41,42] showed alterations in collagen I with no changes in the expression of collagen III [42] or increase in both types of collagen [8,41].

The scarcity and divergences between the works presented in the literature strengthen the importance of this work. The findings confirm our hypothesis that BLE exerts a direct action on the heart, reducing cardiac levels of TNF-α and IL-6. This anti-inflammatory effect is reflected in increased MMP-2 activity, which culminates in reduced protein expression of type III collagen and results in improved cardiac remodeling. Future studies are needed to address the mechanisms by which inflammatory cytokines modulate the activity of metalloproteinases in cardiac remodeling during obesity. Additionally, it is relevant to include female models in future studies to evaluate whether BLE has comparable or distinct effects.

Conclusion

The anti-inflammatory effect of BLE improved cardiac remodeling in obese rats through the regulation of protein expression of the collagen/metalloproteinase axis.

Supporting information

S1 Fig.

Raw image 1. Original gels for Fig 2.

https://doi.org/10.1371/journal.pone.0334015.s001

(PDF)

S2 Fig.

Raw image 2. Original blots for Fig 3.

https://doi.org/10.1371/journal.pone.0334015.s002

(PDF)

S1 Data. Minimal data set.

The minimal data set underlying the findings reported in our study.

https://doi.org/10.1371/journal.pone.0334015.s003

(XLSX)

Acknowledgments

The authors would like to thank the Department of Pharmaceutical Sciences, University of Milan, for supplying the bergamot leaves extract and the Experimental Research Unity (UNIPEX) for supporting research development.

References

  1. 1. Siqueira JS, Nakandakare-Maia ET, Vieira TA, Palacio TLN, Belin MAF, Baron G, et al. Overview of bergamot leaves extract (Citrus bergamia) effect on the RedOx/Inflammatory scenario in obesity target organs in an animal model of metabolic syndrome. Journal of Functional Foods. 2024;113:106042.
  2. 2. Ferron AJT, Francisqueti-Ferron FV, Silva CCVA, Bazan SGZ, Campos DHS, Garcia JL, et al. Tomato-Oleoresin Anti-Inflammatory Effect Recovers Obesity-Induced Cardiac Dysfunction by Modulating Myocardial Calcium Handling. Cell Physiol Biochem. 2020;54(5):1013–25. pmid:33021750
  3. 3. Garcia JL, Vileigas DF, Gregolin CS, Costa MR, Francisqueti-Ferron FV, Ferron AJT, et al. Rice (Oryza sativa L.) bran preserves cardiac function by modulating pro-inflammatory cytokines and redox state in the myocardium from obese rats. Eur J Nutr. 2022;61(2):901–13. pmid:34636986
  4. 4. Oliveira SM, Garcia JL, Vileigas DF, Campos DHS, Francisqueti-Ferron FV, Ferron AJT, et al. Cardiac Remodeling in Obesity-Resistance Model is not Related to Collagen I and III Protein Expression. International Journal of Cardiovascular Sciences. 2021.
  5. 5. Alves PHR, Ferron AJT, Costa MR, Hasimoto FK, Gregolin CS, Garcia JL, et al. Relação entre Resposta Imune Inata do Receptor Toll-Like-4 (TLR-4) e o Processo Fisiopatológico da Cardiomiopatia da Obesidade. Arquivos Brasileiros de Cardiologia. 2021;117(1):91–9.
  6. 6. Nikolov A, Popovski N. Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review. Metabolites. 2022;12(4):297. pmid:35448484
  7. 7. Kruszewska J, Cudnoch-Jedrzejewska A, Czarzasta K. Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix. IJMS. 2022;23(8):4195.
  8. 8. Martínez-Martínez E, Jurado-López R, Valero-Muñoz M, Bartolomé MV, Ballesteros S, Luaces M, et al. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J Hypertens. 2014;32(5):1104–14; discussion 1114. pmid:24695395
  9. 9. Silva-Bertani DCT, Vileigas DF, Mota GAF, Souza SLB, Tomasi LCD, Campos DHS. A redução do colágeno tipo I está associada ao aumento da atividade da metaloproteinase-2 e da expressão proteica de leptina no miocárdio de ratos obesos. Arq Bras Cardiol. 2019;115:61–70.
  10. 10. Lee HS, Kim WJ. The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases. Int J Mol Sci. 2022;23(18):10546. pmid:36142454
  11. 11. Bian Y, Xiang Z, Wang Y, Ren Q, Chen G, Xiang B, et al. Immunomodulatory roles of metalloproteinases in rheumatoid arthritis. Front Pharmacol. 2023;14:1285455. pmid:38035026
  12. 12. Figueiredo AM, Cardoso AC, Pereira BLB, Silva RAC, Ripa AFGD, Pinelli TFB, et al. Açai supplementation (Euterpe oleracea Mart.) attenuates cardiac remodeling after myocardial infarction in rats through different mechanistic pathways. PLoS One. 2022;17(3):e0264854. pmid:35245316
  13. 13. Mukherjee A, Das B. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis. Biomater Biosyst. 2024;13:100090. pmid:38440290
  14. 14. Ribeiro Vitorino T, Ferraz do Prado A, Bruno de Assis Cau S, Rizzi E. MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension. Biochem Pharmacol. 2023;215:115684. pmid:37459959
  15. 15. Baron G, Altomare A, Mol M, Garcia JL, Correa C, Raucci A, et al. Analytical Profile and Antioxidant and Anti-Inflammatory Activities of the Enriched Polyphenol Fractions Isolated from Bergamot Fruit and Leave. Antioxidants (Basel). 2021;10(2):141. pmid:33498213
  16. 16. Gruca D, Wais M, Zając M, Zalewski P, Wróblewski W, Raabe A. Bergamot Polyphenols: Promising Agents for Health and Wellness. J Educ Health Sport. 2024;65:49852.
  17. 17. Russo C, Lombardo GE, Bruschetta G, Rapisarda A, Maugeri A, Navarra M. Bergamot Byproducts: A Sustainable Source to Counteract Inflammation. Nutrients. 2024;16(2):259.
  18. 18. Sun W, Shahrajabian MH. Therapeutic Potential of Phenolic Compounds in Medicinal Plants-Natural Health Products for Human Health. Molecules. 2023;28(4):1845. pmid:36838831
  19. 19. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US). 2011. doi: https://doi.org/10.17226/12910
  20. 20. da Silva-Bertani DCT. Influence of AT1 receptor blockade on myocardial collagens I and III in obese rats fed a saturated high-fat diet. São Paulo State University. 2016. http://hdl.handle.net/11449/146697
  21. 21. Francisqueti FV, Minatel IO, Ferron AJT, Bazan SGZ, Silva VDS, Garcia JL, et al. Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet. Nutrients. 2017;9(12):1299. pmid:29186059
  22. 22. Nakandakare-Maia ET, Siqueira JS, Ferron AJT, Vieira TA, Palacio TLN, Grandini NA, et al. Treatment with bergamot (Citrus bergamia) leaves extract attenuates leptin resistance in obese rats. Mol Cell Endocrinol. 2023;566–567:111908. pmid:36868453
  23. 23. Siqueira JS, Vieira TA, Nakandakare-Maia ET, Palacio TLN, Sarzi F, Garcia JL, et al. Bergamot leaf extract treats cardiorenal metabolic syndrome and associated pathophysiological factors in rats fed with a high sugar fat diet. Mol Cell Endocrinol. 2022;556:111721. pmid:35917880
  24. 24. Musolino V, Gliozzi M, Scarano F, Bosco F, Scicchitano M, Nucera S, et al. Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease. Sci Rep. 2020;10(1):2565. pmid:32054943
  25. 25. Francisqueti-Ferron FV, Garcia JL, Ferron AJT, Nakandakare-Maia ET, Gregolin CS, Silva JP das C, et al. Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?. Mol Cell Endocrinol. 2021;520:111095. pmid:33253762
  26. 26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. pmid:3899825
  27. 27. Santos PPD, Rafacho BPM, Gonçalves A de F, Jaldin RG, Nascimento TB, Silva MAB, et al. Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties. PLoS One. 2014;9(6):e98895. pmid:24921930
  28. 28. Tyagi SC, Matsubara L, Weber KT. Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem. 1993;26(3):191–8. pmid:8330388
  29. 29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 1976;72(1–2):248–54.
  30. 30. Polegato BF, Minicucci MF, Azevedo PS, Carvalho RF, Chiuso-Minicucci F, Pereira EJ, et al. Acute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in rats. Cell Physiol Biochem. 2015;35(5):1924–33. pmid:25871735
  31. 31. Jin X, Qiu T, Li L, Yu R, Chen X, Li C, et al. Pathophysiology of obesity and its associated diseases. Acta Pharm Sin B. 2023;13(6):2403–24. pmid:37425065
  32. 32. Belin MAF, Vieira TA, Grandini NA, Siqueira JS, Palacio TLN, Cruzeiro J, et al. Cardiac biogenic amine profile and its relationship with parameters of cardiovascular disease in obesity. Vascul Pharmacol. 2024;156:107412. pmid:39033868
  33. 33. Della Vedova L, Gado F, Vieira TA, Grandini NA, Palácio TLN, Siqueira JS, et al. Chemical, Nutritional and Biological Evaluation of a Sustainable and Scalable Complex of Phytochemicals from Bergamot By-Products. Molecules. 2023;28(7):2964. pmid:37049725
  34. 34. Martins F, Campos DHS, Pagan LU, Martinez PF, Okoshi K, Okoshi MP, et al. High-fat Diet Promotes Cardiac Remodeling in an Experimental Model of Obesity. Arq Bras Cardiol. 2015;105(5):479–86. pmid:26291841
  35. 35. Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022;14(2):e22711. pmid:35386146
  36. 36. Zhang H, Dhalla NS. The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. IJMS. 2024;25(2):1082.
  37. 37. Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuña JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int J Mol Sci. 2020;21(24):9739. pmid:33419373
  38. 38. Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, et al. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. Journal of Cardiology. 2014;63(5):373–8.
  39. 39. DeLeon-Pennell KY, Meschiari CA, Jung M, Lindsey ML. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. Prog Mol Biol Transl Sci. 2017;147:75–100. pmid:28413032
  40. 40. Dantas D, Pereira AG, Fujimori ASS, Ribeiro APD, de Almeida Silva CCV, Monte MG, et al. Doxycycline Attenuates Doxorubicin-Induced Cardiotoxicity by Improving Myocardial Energy Metabolism in Rats. J Cardiovasc Dev Dis. 2022;9(8):254. pmid:36005418
  41. 41. Carroll JF, Tyagi SC. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens. 2005;18(5 Pt 1):692–8. pmid:15882553
  42. 42. da Silva DCT, Lima-Leopoldo AP, Leopoldo AS, Campos DHS, Nascimento AF, Oliveira Junior SA, et al. Influence of Term of Exposure to High-Fat Diet-Induced Obesity on Myocardial Collagen Type I and III. Arquivos Brasileiros de Cardiologia. 2013.